• 1
    Anderle SK, Greenblatt JJ, Cromartie WJ, Clark R, Schwab JH. Modulation of the susceptibility of inbred and outbred rats to arthritis induced by cell walls of group A streptococci. Infect Immun 1979; 25: 48490.
  • 2
    Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN. Contact activation pathway: inflammatory, fibrinolytic, anticoagulant, antiadhesive, and antiangiogenic activities. In: ColmanRW, editor. Hemostasis and thrombosis, basic principles and clinical practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 10321.
  • 3
    Toossi Z, Sedor JR, Mettler MA, Everson B, Young T, Ratnoff OD. Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII). Proc Natl Acad Sci U S A 1992; 89: 1196972.
  • 4
    Joseph K, Tholanikunnel BG, Kaplan AP. Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc Natl Acad Sci U S A 2002; 99: 896900.
  • 5
    Shariat-Madar Z, Mahdi F, Schmaier AH. Recombinant prolylcarboxypeptidase activates plasma prekallikrein. Blood 2004; 103: 455461.
  • 6
    Gallin JI, Kaplan AP. Mononuclear cell chemotactic activity of kallikrein and plasminogen activator and its inhibition by C1 inhibitor and α2-macroglobulin. J Immunol 1974; 113: 192834.
  • 7
    Kaplan AP, Joseph K, Silverberg M. Pathways for bradykinin formation and inflammatory disease [review]. J Allergy Clin Immunol 2002; 109: 195209.
  • 8
    Khan MM, Bradford HN, Isordia-Salas I, Espinola R, Colman RW. High molecular weight kininogen fragments stimulate the secretion of interleukin-1β through the urokinase-type plasminogen activator receptor (u-P-R) and CD11b/CD18 (Mac-1) in human blood mononuclear cells [abstract]. Blood 2004; 104: 36b.
  • 9
    Isordia-Salas I, Pixley RA, Li F, Sainz I, Sartor RB, Adam A, et al. Kininogen deficiency modulates chronic intestinal inflammation in genetically susceptible rats. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1806.
  • 10
    Isordia-Salas I, Pixley RA, Parekh H, Kunapuli SP, Li F, Stadnicki A, et al. The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation. Blood 2003; 102: 283542.
  • 11
    Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971; 53: 52337.
  • 12
    Espinola RG, Uknis A, Sainz IM, Isordia-Salas I, Pixley R, DeLa Cadena R, et al. A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis. Am J Pathol 2004; 165: 96976.
  • 13
    Keith JJ, Sainz IM, Isordia-Salas I, Pixley RA, Leathurby Y, Albert LM, et al. A monoclonal antibody against kininogen reduces inflammation in the HLA-B27 transgenic rat. Arthritis Res Ther 2005; 7: R76976.
  • 14
    Ueno A, Oh-ishi S. Roles for the kallikrein-kinin system in inflammatory exudation and pain: lessons from studies on kininogen-deficient rats [review]. J Pharmacol Sci 2003; 93: 120.
  • 15
    Hayashi I, Amano H, Yoshida S, Kamata K, Kamata M, Inukai M, et al. Suppressed angiogenesis in kininogen-deficiencies. Lab Invest 2002; 82: 87180.
  • 16
    Parenti A, Morbidelli L, Ledda F, Granger HJ, Ziche M. The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway. FASEB J 2001; 15: 14879.